Page 2 - Eli Lilly

Eli Lilly memo says firm did not make false statements to FDA

(Reuters) - A week before Eli Lilly disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters.

BDR Pharma inks licensing pact with Eli Lilly for Covid-19 treatment drug

Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution of Baricitinib for the treatment of Covid-19 in India

Eli Lilly inks pact with Natco Pharma for Covid-19 drug baricitinib

Drug firm Eli Lilly said it has signed a voluntary licensing agreement with Natco Pharma to further expedite the availability of baricitinib for Covid-19 patients in India

Torrent Pharma inks pact with Eli Lilly for Covid drug Baricitinib in India

Under royalty-free, non-exclusive deal, Torrent can make and sell baricitinib in India along with the US firm's other license partners

Lilly signs 3 pacts to expand availability of baricitinib for Covid patient

Eli Lilly has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals

Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug

Olumiant, or Baricitinib, is an oral drug developed by US biopharmaceutical major, Incyte Corporation, and licensed to Eli Lilly

Eli Lilly signs deals to boost supply of Covid-19 treatment in India

The firm has signed licensing agreements with three Indian generic drugmakers to expand the availability of the drug baricitinib

Cipla inks pact with Eli Lilly to produce, sell Covid-19 treatment drug

Drug major Cipla on Monday said it has inked a pact with US-based Eli Lilly and Company to manufacture and produce baricitinib in the country for the treatment of Covid-19

Insider alleges Eli Lilly blocked her efforts to sound alarms on drug plant

Lilly is working closely with the FDA to address concerns about the factory,

Eli Lilly's combo therapy for Covid-19 gets good results

Eli Lilly & Co.'s combination antibody therapy reduced the risk of hospitalization or death by 87% in high-risk patients with newly-diagnosed Covid-19, the company said

Eli Lilly says CFO resigns after 'inappropriate communication' with staff

Eli Lilly had taken "swift and significant action" as soon as it learned about the allegations, a company spokeswoman told Reuters

WHO advises doctors against using Gilead's remdesivir for treating Covid-19

The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit to coronavirus patients after a study showed it reduced their recovery time

Eli Lilly's Covid-19 antibody drug treatment gets emergency USFDA clearance

The FDA authorised the experimental treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adults, including those who are 65 and older, and pediatric patients

Eli Lilly ready to ship 100,000 doses of Covid drug; waiting for FDA nod

The initial agreement is for delivery over the first two months following an emergency authorisation

Eli Lilly to continue other Covid-19 antibody drug trials after pausing one

Lilly said the government-sponsored clinical trial of its Covid-19 antibody treatment, which is similar to one taken by U.S. President Donald Trump, had been paused over safety concerns.

Race for coronavirus cure hits reality as clinic complications mount

Regulators and drugmakers have faced questions about whether political pressure was overwhelming scientific rigor ahead of the presidential election on Nov. 3

Lilly halts trial of antibody drug Trump touted as cure over safety concern

Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his Covid-19, as tantamount to a cure in a video he posted last week

US drugmaker Eli Lilly starts phase 3 trial for Covid-19 antibody treatment

The first-of-its-kind study is expected to enrol up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19

Coronavirus: Eli Lilly starts testing; Gilead drug shows positive signs

Lilly said it currently does not anticipate shortages for any of its medicines, including baricitinib

Eli Lilly to buy cancer treatment company Loxo Oncology for $8 bn in cash

The cash deal comes on the heels of Bristol-Myers Squibb Co's agreement last week to buy Celgene Corp for $74 billion in the largest pharmaceutical deal ever